EQRx
Biotechnology ResearchMassachusetts, United States201-500 Employees
Effective 11/09/23, EQRx., Inc. is now a wholly-owned subsidiary of Revolution Medicines (https://www.revmed.com/)
Mergers & Acquisitions Possibilities EQRx is actively involved in mergers and acquisitions, such activities can present sales opportunities for service providers offering legal, financial advisory, or consultancy services.
Legal Investigation Services Current shareholder investigations and potential legal actions involving EQRx indicate a need for legal services. Law firms specializing in corporate litigations and investigations may find sales prospects within this context.
Investor Relations Solutions With ongoing investor alerts and investigations related to EQRx, there is a potential market for investor relations firms to offer strategic communications and advisory services to the company and its shareholders.
Financial Consultancy Opportunites The significant funding and financials of EQRx suggest a demand for financial advisory and consultancy services. Companies providing financial analysis, valuation, or funding strategies could explore sales opportunities with EQRx.
Tech Integration Services The diverse tech stack utilized by EQRx indicates a reliance on technology for operations. Technology service providers offering integration solutions, software development, or IT consulting may find potential sales leads within EQRx.
EQRx uses 8 technology products and services including Drupal, GitLab, ScrollReveal, and more. Explore EQRx's tech stack below.
EQRx Email Formats | Percentage |
FLast@eqrx.com | 94% |
Last@eqrx.com | 4% |
FMiddleLast@eqrx.com | 1% |
FL@eqrx.com | 1% |
FLast@revmed.com | 80% |
First@revmed.com | 19% |
Last@revmed.com | 1% |
Biotechnology ResearchMassachusetts, United States201-500 Employees
Effective 11/09/23, EQRx., Inc. is now a wholly-owned subsidiary of Revolution Medicines (https://www.revmed.com/)
EQRx has raised a total of $1.2B of funding over 3 rounds. Their latest funding round was raised on Dec 17, 2021 in the amount of $1.2B.
EQRx's revenue is in the range of $10M$50M
EQRx has raised a total of $1.2B of funding over 3 rounds. Their latest funding round was raised on Dec 17, 2021 in the amount of $1.2B.
EQRx's revenue is in the range of $10M$50M